Related Experiment Video
Updated: Nov 21, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Dilatation of the aorta in children with advanced chronic kidney disease
Sophie Quennelle1, Caroline Ovaert1, Mathilde Cailliez2
1Paediatric Cardiology Department, La Timone Hospital, Aix-Marseille University, Marseille, France.
Insights
Children with advanced chronic kidney disease (CKD) show a high prevalence of ascending aorta dilation. This arterial vulnerability is linked to hypertension, arteriovenous fistula, and hemodialysis treatments in pediatric CKD patients.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Medicine
- Medical Imaging
Background:
- Adults with chronic kidney disease (CKD) exhibit increased arterial vulnerability and cardiovascular risk.
- This risk is attributed to traditional factors, uremic comorbidities, and cardiorenal syndrome (CRS).
- The cardiovascular impact of uremia in pediatric advanced CKD remains less understood.
Purpose of the Study:
- To investigate the cardiovascular impact of uremic condition in pediatric patients with advanced CKD.
- To determine the prevalence of arterial abnormalities, specifically ascending aorta dilation, in this population.
- To identify associated clinical and treatment-related factors.
Main Methods:
- Echocardiographic evaluation of 39 consecutive pediatric patients with advanced CKD between 2016-2018.
- Collection of demographic, clinical, biological, and echocardiographic data.
- Univariate analysis to identify factors associated with aortic dilation.
Main Results:
- Mean age was 9.7 ± 4.6 years; 61.5% were on hemodialysis.
- Hypertension (76.9%) and left ventricular hypertrophy (33.3%) were common.
- Ascending aorta dilation (Z-score > 2) was found in 38.4% of patients.
Conclusions:
- Advanced CKD in children is associated with a high prevalence of ascending aorta dilation.
- Hypertension, arteriovenous fistula (AVF), and hemodialysis were significantly associated with aortic dilation.
- These findings highlight increased arterial vulnerability in pediatric CKD patients.
Background:
The peculiarity of the cardiovascular risk profile with increased arterial vulnerability is well known in adults with chronic kidney disease (CKD). It is explained by an increased incidence of traditional cardiovascular risk factors together with other comorbidities related to the uremic condition and cardiorenal syndrome (CRS). The present study aimed to determine the cardiovascular impact of the uremic condition in a pediatric population with advanced CKD.
Methods:
From 2016 to 2018, 39 consecutive patients with advanced CKD who underwent echocardiographic evaluation were included. All echocardiographic examinations were performed by the same operator (FE). Demographic, clinical, biological, and echocardiographic data were collected.
Results:
The mean age at echocardiographic exam was 9.7 ± 4.6 years. Twenty-four (61.5%) patients were on hemodialysis; 17 (43.6%) patients were in a peritoneal dialysis program of whom 11 switched at a later stage to hemodialysis. Eight (20.5%) patients had an arteriovenous fistula (AVF). Hypertension was present in 30 (76.9%) patients while left ventricular hypertrophy (LVH) was described in 13 (33.3%) patients. Dilatation of the ascending aorta (Z-score > 2) was found in 15 (38.4%) patients and was statistically (in univariate analysis) related to gender, hypertension, the presence of an AVF, and the use of hemodialysis after peritoneal dialysis (p = 0.024, p = 0.016, p = 0.006, p = 0.009, respectively).
Conclusion:
In addition to classical and predictable abnormalities related to CKD, we found a high prevalence of dilatation of the ascending aorta in children with advanced CKD. Hypertension, AVF, and hemodialysis were associated factors.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Aortic Regurgitation III: Medical Management

